Risk stratification of immunocompromised children, including pediatric transplant recipients at risk of severe respiratory syncytial virus disease-Reference-Cited by-同舟云学术

Risk stratification of immunocompromised children, including pediatric transplant recipients at risk of severe respiratory syncytial virus disease

Published:2019-01-03 Issue:2 Volume:23 Page:e13336
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Science Michelle¹,Akseer Nadia²³,Asner Sandra⁴,Allen Upton¹³⁵^ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Paediatrics; The Hospital for Sick Children; Toronto Ontario Canada

2. Centre for Global Child Health; The Hospital for Sick Children; Toronto Ontario Canada

3. University of Toronto; Toronto Ontario Canada

4. Pediatric Infectious Diseases Unit, Department of Pediatrics; University Hospital Lausanne; Lausanne Switzerland

5. Child Health Evaluative Sciences; The Hospital for Sick Children; Toronto Ontario Canada

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.13336/fullpdf

Reference28 articles.

1. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection;American Academy of Pediatrics Committee on Infectious Diseases;Pediatrics,2014

2. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment;Domachowske;Clin Microbiol Rev,1999

3. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group;Pediatrics,1998

4. Preventing hospitalizations for respiratory syncytial virus infection;Robinson;Paediatr Child Health,2015

5. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients;Chavez-Bueno;Pediatr Infect Dis J,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for severe disease in pediatric respiratory syncytial virus infections;Public Health;2024-10

2. In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections;Virology;2023-09

3. Full Genome Characterization of Respiratory Syncytial Virus Causing a Fatal Infection in an Immunocompromised Patient in Tunisia;Pathogens;2022-07-02

4. Antiviral Therapeutics in Pediatric Transplant Recipients;Infectious Disease Clinics of North America;2022-03

5. Hospital Epidemiology and Infection Control in the Transplant Center;Emerging Transplant Infections;2021